Who will consent to emergency treatment trials for subarachnoid hemorrhage?

Academic Emergency Medicine

Volumn 16, Issue 4, 2009, Pages 309-315

  Giudice, Angela Del ^a   Plaum, Justin ^a   Maloney, Eileen ^a   Kasner, Scott E ^a   Le Roux, Peter D ^a   Baren, Jill M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Clinical trials; Emergency research; Informed consent; Subarachnoid hemorrhage

Indexed keywords

ADULT; AGED; AMBULATORY CARE; ANAMNESIS; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; EMERGENCY TREATMENT; EMERGENCY WARD; ETHNICITY; FAMILY HISTORY; FEMALE; HEALTH CARE ACCESS; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELIGION; SUBARACHNOID HEMORRHAGE;

ADOLESCENT; ADULT; AGED; BLOOD TRANSFUSION; CHOICE BEHAVIOR; CROSS-SECTIONAL STUDIES; EMERGENCY TREATMENT; FAMILY; FEMALE; HEALTH PERSONNEL; HOSPITALS, UNIVERSITY; HUMANS; INFORMED CONSENT; MALE; MENTAL COMPETENCY; MIDDLE AGED; PHILADELPHIA; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUBJECTS; SUBARACHNOID HEMORRHAGE; THIRD-PARTY CONSENT; YOUNG ADULT;

EID: 65249084045     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2009.00367.x     Document Type: Article

References (39)

1. Rosamond W, Flegal K, Furie K, et al. for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2008 Update. Circulation. 2008; 117:e25-e146.
2. de RooijNK, Linn FHH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007; 78:1365-72.
3. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997; 28:660-4.
4. Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from sub- arachnoid hemorrhage. Neurology. 1998; 50:1413-8.
5. Hackett ML, Anderson CS. Health outcomes 1 year after subarachnoid hemorrhage: an international population-based study. The Australian Cooperative Research on Subarachnoid Hemorrhage Study Group. Neurology. 2000; 55:658-62.
6. Molyneux AJ, Kerr RSC, Yu LM, et al., for the International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005; 366:809-17.
7. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006; 355:928-39.
8. Solenski NJ, Haley EC Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Crit Care Med. 1995; 23:1007-17.
9. Wartenberg KE, Mayer SA. Medical complications after subarachnoid hemorrhage: new strategies for prevention and management. Crit Care Med. 2006; 34:617-23.
10. Naidech AM, Drescher J, Ault ML, Shaibani A, Hunt Batjer H, Alberts MJ. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery. 2006; 59:775-80.
11. Le Roux P, Elliott JP, Winn HR. Blood transfusion during aneurysm surgery. Neurosurgery. 2001; 49:1068-75.
12. Naidech AM, Jovanovic B, Wartenberg KE, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med. 2007; 35:2383-9.
13. Couture DE, Ellegala DB, Dumont AS, Mintz PD, Kassell NF. Blood use in cerebrovascular neurosurgery. Stroke. 2002; 33:994-7.
14. Wartenberg KE, Schmidt JM, Fernandez A, et al. Impact of Red Blood Cell Transfusion on Outcome after Subarachnoid Hemorrhage. 5th Annual Neur- ocritical Care Society Meeting, Las Vegas, NV, November 2007.
15. Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kas- sell NF, Bleck TP. Complications associated with anemia and blood transfusion in patients with aneu- rysmal subarachnoid hemorrhage. Crit Care Med. 2008; 36:2070-5.
16. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg. 2004; 101:1-7.
17. Hebert PC, Wells G, Blajchman MA, et al. A multi-center, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340:409-17.
18. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med. 2004; 32:39-52.
19. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002; 288:1499-507.
20. Baren JM, Anicetti JP, Ledesma S, Biros MH, Ma- habee-Gittens M, Lewis RJ. An approach to community consultation prior to initiating an emergency research study incorporating a waiver of informed consent. Acad Emerg Med. 1999; 6:1210-5.
21. McRae A, Weijer C. U.S. federal regulations for emergency research: a practical guide and commentary. Acad Emerg Med. 2008; 15:88-97.
22. McClure KB, DeIorio NM, Gunnels MD, Ochsner MJ, Biros MH, Schmidt TA. Attitudes of emergency department patients and visitors regarding emergency exception from informed consent in resuscitation research, community consultation, and public notification. Acad Emerg Med. 2003; 10:352-9.
23. Patel A, Wilke HJ, Mingay D, Ellis JE. Patient attitudes toward granting consent to participate in perioperative randomized clinical trials. J Clin Anesth. 2004; 16:426-34.
24. Carey MP, Senn TE, Vanable PA, Coury-Doniger P, Urban MA. Do STD clinic patients who consent to sexual health research differ from those who decline? Findings from a randomized controlled trial with implications for the generalization of research results. Sex Transm Dis. 2008; 35:73-7.
25. Peterson E, Lytle BL, Biswas MS, Combs L. Willingness to participate in cardiac trials. Am J Geriatr Cardiol. 2004; 13:11-5.
26. Lee D. Perception of blood transfusion risk. Trans- fus Med Rev. 2006; 20:141-8.
27. Moxey AJ, O'Connell DL, Treloar CJ, et al. Blood transfusion and autologous donation: a survey of post-surgical patients, interest group members and the public. Transfus Med. 2005; 15:19-32.
28. Filucane ML, Slovic P, Mertz CK. Public perception of the risk of blood transfusion. Transfusion. 2000; 40:1017-22.
29. Koops L, Lindley RI. Thrombolysis for acute stroke: consumer involvement in design of new randomized controlled trial. BMJ. 2002; 325:415-9.
30. Kim SY, Kim HM, McCallum C, Tariot PN. What do people at risk for Alzheimer disease think about surrogate consent for research? Neurology. 2005; 65:1395-401.
31. Karlawish J, Kim SY, Knopman D, van Dyck CH, James BD, Marson D. The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment. Am J Geriatr Psychiatry. 2008; 16:240-7.
32. Blixen CE, Agich GJ. Stroke patients preferences and values about emergency research. J Med Ethics. 2005; 31:608-11.
33. Ali K, Roffe C, Crome P. What patients want. Consumer involvement in the design of a randomized controlled trial of routine oxygen supplementation after acute stroke. Stroke. 2006; 37:865-71.
34. Stephenson AC, Baker S, Zeps N. Attitudes of relatives of patients in intensive care and emergency departments to surrogate consent to research on incapacitated participants. Crit Care Resusc. 2007; 9:40-50.
35. Ciroldi M, Cariou A, Adrie C, et al. Ability of family members to predict patient's consent to critical care research. Inten Care Med. 2007; 33:807-13.
36. Shalowitz DI, Garrett-Mayer E, Wendler D. The accuracy of surrogate decision makers. Arch Intern Med. 2006; 166:493-7.
37. Leggett CG, Kleckner NS, Boyle KJ, Duffield JW, Mitchell RC. Social desirability bias in contingent valuation surveys administered through in-person interviews. Land Econ. 2003; 79:561-75.
38. Halpern SD, Metzger DS, Berlin JA, Ubel PA. Who will enroll? Predicting participation in a phase II AIDS vaccine trial. J Acquir Immune Defic Syndr. 2001; 27:281-8.
39. Halpern SD. Prospective preference assessment: a method to enhance the ethics and efficiency of randomized controlled trials. Control Clin Trials. 2002; 23:274-88.